Cambridge Investment Research Advisors’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$692K Buy
3,111
+225
+8% +$40.9K ﹤0.01% 2453
2026
Q1
$444K Buy
2,886
+166
+6% +$22.5K ﹤0.01% 2911
2025
Q4
$309K Sell
2,720
-171
-6% -$20.8K ﹤0.01% 3172
2025
Q3
$384K Buy
2,891
+1
+0% +$137 ﹤0.01% 2901
2025
Q2
$412K Sell
2,890
-153
-5% -$21.7K ﹤0.01% 2713
2025
Q1
$465K Sell
3,043
-10,982
-78% -$1.73M ﹤0.01% 2516
2024
Q4
$2.1M Buy
14,025
+5,543
+65% +$869K 0.01% 1323
2024
Q3
$1.39M Buy
8,482
+2,538
+43% +$375K ﹤0.01% 1613
2024
Q2
$824K Buy
5,944
+2,162
+57% +$298K ﹤0.01% 1908
2024
Q1
$522K Buy
3,782
+1,396
+59% +$167K ﹤0.01% 2243
2023
Q4
$250K Buy
+2,386
New +$220K ﹤0.01% 2736
2022
Q4
Sell
-3,225
Closed -$267K 3124
2022
Q3
$267K Sell
3,225
-52
-2% -$4.56K ﹤0.01% 2461
2022
Q2
$262K Sell
3,277
-274
-8% -$27.7K ﹤0.01% 2500
2022
Q1
$402K Buy
3,551
+242
+7% +$27.2K ﹤0.01% 2287
2021
Q4
$376K Buy
3,309
+364
+12% +$39.1K ﹤0.01% 2334
2021
Q3
$342K Buy
2,945
+101
+4% +$12.6K ﹤0.01% 2355
2021
Q2
$343K Buy
2,844
+127
+5% +$15K ﹤0.01% 2371
2021
Q1
$293K Buy
2,717
+124
+5% +$13.8K ﹤0.01% 2299
2020
Q4
$304K Sell
2,593
-1,500
-37% -$153K ﹤0.01% 2129
2020
Q3
$351K Buy
4,093
+15
+0.4% +$1.28K ﹤0.01% 1828
2020
Q2
$323K Sell
4,078
-792
-16% -$61.8K ﹤0.01% 1837
2020
Q1
$370K Sell
4,870
-3,455
-42% -$272K ﹤0.01% 1551
2019
Q4
$625K Sell
8,325
-1,643
-16% -$109K ﹤0.01% 1435
2019
Q3
$569K Buy
9,968
+4,275
+75% +$248K 0.01% 1417
2019
Q2
$320K Sell
5,693
-310
-5% -$16.1K ﹤0.01% 1710
2019
Q1
$326K Sell
6,003
-189
-3% -$10.5K ﹤0.01% 1754
2018
Q4
$319K Sell
6,192
-186
-3% -$11.9K ﹤0.01% 1622
2018
Q3
$457K Sell
6,378
-502
-7% -$35.5K ﹤0.01% 1497
2018
Q2
$478K Sell
6,880
-1,514
-18% -$101K 0.01% 1420
2018
Q1
$554K Sell
8,394
-1,128
-12% -$82.8K 0.01% 1290
2017
Q4
$688K Sell
9,522
-2,866
-23% -$176K 0.01% 1117
2017
Q3
$736K Sell
12,388
-5,847
-32% -$352K 0.01% 999
2017
Q2
$1.18M Sell
18,235
-100
-0.5% -$6.62K 0.02% 727
2017
Q1
$1.25M Buy
18,335
+1,391
+8% +$92.1K 0.02% 635
2016
Q4
$1.09M Sell
16,944
-1,328
-7% -$82.7K 0.02% 632
2016
Q3
$1.21M Sell
18,272
-178
-1% -$12.5K 0.02% 599
2016
Q2
$1.43M Sell
18,450
-1,644
-8% -$124K 0.03% 469
2016
Q1
$1.47M Sell
20,094
-32
-0.2% -$2.16K 0.03% 428
2015
Q4
$1.4M Buy
20,126
+523
+3% +$38.3K 0.03% 445
2015
Q3
$1.42M Buy
19,603
+1,288
+7% +$99.9K 0.04% 388
2015
Q2
$1.46M Buy
18,315
+4
+0% +$328 0.04% 389
2015
Q1
$1.49M Buy
18,311
+478
+3% +$36.7K 0.04% 370
2014
Q4
$1.35M Buy
17,833
+900
+5% +$67.8K 0.04% 397
2014
Q3
$1.24M Buy
16,933
+1,345
+9% +$98.5K 0.04% 443
2014
Q2
$1.13M Buy
15,588
+1,345
+9% +$93.5K 0.04% 424
2014
Q1
$981K Buy
14,243
+2,987
+27% +$198K 0.04% 429
2013
Q4
$713K Buy
11,256
+400
+4% +$23.5K 0.03% 505
2013
Q3
$618K Buy
10,856
+2,224
+26% +$127K 0.03% 530
2013
Q2
$521K Buy
+8,632
New +$539K 0.03% 528

Other funds holding DVA

Cambridge Investment Research Advisors's DVA Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its DaVita (DVA) stake by 7.8% in Q2 2026, buying an estimated $40.9K and bringing the position to 3,111 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Cambridge Investment Research Advisors first reported a position in DVA in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.1M in Q4 2024. 142 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Cambridge Investment Research Advisors held 3,111 shares of DaVita worth $692K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 225 DaVita shares in Q2 2026, an estimated $40.9K.
  • DaVita made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2453 holding.
  • Cambridge Investment Research Advisors first reported a position in DaVita in Q2 2013 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's DaVita position peaked at $2.1M in Q4 2024.
  • 142 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.